VCM
MDCO

Versant Capital Management’s Medicines Co MDCO Stock Holding History

Versant Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-173
Closed -$8K – 1712
2019
Q3 		$8K Buy
173
+43
+33% +$1.72K ﹤0.01% 821
2019
Q2 		$4K Sell
130
-214
-62% -$6.99K ﹤0.01% 1065
2019
Q1 		$9K Sell
344
-147
-30% -$3.46K ﹤0.01% 959
2018
Q4 		$9K Sell
491
-54
-10% -$1.26K ﹤0.01% 870
2018
Q3 		$16K Buy
545
+30
+6% +$1.13K 0.01% 745
2018
Q2 		$18K Sell
515
-78
-13% -$2.54K 0.01% 680
2018
Q1 		$19K Buy
593
+4
+0.7% +$125 0.01% 661
2017
Q4 		$16K Sell
589
-208
-26% -$6.41K 0.01% 754
2017
Q3 		$29K Sell
797
-14
-2% -$516 0.02% 436
2017
Q2 		$30K Buy
811
+183
+29% +$8.15K 0.02% 420
2017
Q1 		$30K Buy
628
+151
+32% +$6.89K 0.02% 432
2016
Q4 		$16K Sell
477
-116
-20% -$4.11K 0.01% 681
2016
Q3 		$22K Buy
593
+84
+17% +$3.17K 0.01% 540
2016
Q2 		$17K Buy
509
+16
+3% +$564 0.01% 600
2016
Q1 		$15K Sell
493
-465
-49% -$15.2K 0.01% 627
2015
Q4 		$35K Buy
+958
New +$36.2K 0.02% 324

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Versant Capital Management's MDCO Position: Q4 2019 in Review

Versant Capital Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 173 shares — an estimated $8K sold.

Versant Capital Management first reported a position in MDCO in Q4 2015 and held it in 16 quarters. The position peaked at $35K in Q4 2015. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Versant Capital Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Versant Capital Management sold 173 Medicines Co shares in Q4 2019, an estimated $8K.
  • Versant Capital Management first reported a position in Medicines Co in Q4 2015 and held it in 16 quarters.
  • Versant Capital Management's Medicines Co position peaked at $35K in Q4 2015.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Versant Capital Management's 13F filing for Q4 2019, filed 28 Jan 2020.